Marcus Wilson is President of HealthCore, WellPoint’s wholly-owned outcomes research subsidiary. He has been extensively involved in efforts to utilize electronic healthcare data for evidence development and clinical decision support for innovators, regulators and payers for more than 20 years. Prior to co-founding HealthCore in 1996, Dr. Wilson spent seven years within a large group practice setting providing physician and patient clinical decision support, effectively integrating ancillary services into a broader health outcomes approach for patient care.
In addition to his role as Chair of the IMEDS Steering Committee, Dr. Wilson is member of the FDA Mini-Sentinel Program’s Project Operations Council, the Brookings Active Safety Surveillance Council, the eHealth Initiative Board of Directors, the Board of Visitors for the Mayes College of Healthcare Business & Policy at the University of Sciences in Philadelphia and the 2020 Vision Task Force for the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). He is a past member of the Board of Directors for ISPOR and is a reviewer for multiple journals.
Dr. Wilson received his Bachelor of Science in Biochemistry from Virginia Tech and his Doctor of Pharmacy degree from the Medical College of Virginia. He completed a residency in Family Medicine at the Medical University of South Carolina prior to joining the faculty at the Philadelphia College of Pharmacy where he taught didactic and experiential courses in clinical therapeutics and decision support.